» Articles » PMID: 33851758

Multivalent Tryptophan- and Tyrosine-Containing [60]Fullerene Hexa-Adducts As Dual HIV and Enterovirus A71 Entry Inhibitors

Overview
Journal Chemistry
Specialty Chemistry
Date 2021 Apr 14
PMID 33851758
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Unprecedented 3D hexa-adducts of [60]fullerene peripherally decorated with twelve tryptophan (Trp) or tyrosine (Tyr) residues have been synthesized. Studies on the antiviral activity of these novel compounds against HIV and EV71 reveal that they are much more potent against HIV and equally active against EV71 than the previously described dendrimer prototypes AL-385 and AL-463, which possess the same number of Trp/Tyr residues on the periphery but attached to a smaller and more flexible pentaerythritol core. These results demonstrate the relevance of the globular 3D presentation of the peripheral groups (Trp/Tyr) as well as the length of the spacer connecting them to the central core to interact with the viral envelopes, particularly in the case of HIV, and support the hypothesis that [60]fullerene can be an alternative and attractive biocompatible carbon-based scaffold for this type of highly symmetrical dendrimers. In addition, the functionalized fullerenes here described, which display twelve peripheral negatively charged indole moieties on their globular surface, define a new and versatile class of compounds with a promising potential in biomedical applications.

Citing Articles

Click Chemistry as an Efficient Toolbox for Coupling Sterically Hindered Molecular Systems to Obtain Advanced Materials for Nanomedicine.

Cabrera-Quinones N, Lopez-Mendez L, Cruz-Hernandez C, Guadarrama P Int J Mol Sci. 2025; 26(1.

PMID: 39795895 PMC: 11719597. DOI: 10.3390/ijms26010036.


Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies.

Zhang J, Liu Y, Zhi X, Xu L, Tao J, Cui D Inflamm Res. 2024; 73(6):979-996.

PMID: 38592457 DOI: 10.1007/s00011-024-01878-5.


Advances in anti-EV-A71 drug development research.

Wang S, Pang Z, Fan H, Tong Y J Adv Res. 2023; 56:137-156.

PMID: 37001813 PMC: 10834817. DOI: 10.1016/j.jare.2023.03.007.


A 3D Peptide/[60]Fullerene Hybrid for Multivalent Recognition.

Gallego I, Ramos-Soriano J, Mendez-Ardoy A, Cabrera-Gonzalez J, Lostale-Seijo I, Illescas B Angew Chem Int Ed Engl. 2022; 61(41):e202210043.

PMID: 35989251 PMC: 9826239. DOI: 10.1002/anie.202210043.


Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors.

Ramos-Soriano J, Illescas B, Perez-Sanchez A, Sanchez-Bento R, Lasala F, Rojo J Int J Mol Sci. 2022; 23(9).

PMID: 35563489 PMC: 9131134. DOI: 10.3390/ijms23095083.


References
1.
Engstrom O, Munoz A, Illescas B, Martin N, Ribeiro-Viana R, Rojo J . Investigation of glycofullerene dynamics by NMR spectroscopy. Org Biomol Chem. 2015; 13(32):8750-5. DOI: 10.1039/c5ob00929d. View

2.
Bosi S, Da Ros T, Spalluto G, Prato M . Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem. 2003; 38(11-12):913-23. DOI: 10.1016/j.ejmech.2003.09.005. View

3.
Nierengarten J, Iehl J, Oerthel V, Holler M, Illescas B, Munoz A . Fullerene sugar balls. Chem Commun (Camb). 2010; 46(22):3860-2. DOI: 10.1039/c0cc00034e. View

4.
Haqqani A, Tilton J . Entry inhibitors and their use in the treatment of HIV-1 infection. Antiviral Res. 2013; 98(2):158-70. DOI: 10.1016/j.antiviral.2013.03.017. View

5.
Wilen C, Tilton J, Doms R . Molecular mechanisms of HIV entry. Adv Exp Med Biol. 2012; 726:223-42. DOI: 10.1007/978-1-4614-0980-9_10. View